Paediatric Orthopaedic Department, University Children's Hospital (UKBB), Basel, Switzerland.
Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland.
Anticancer Res. 2022 Nov;42(11):5443-5447. doi: 10.21873/anticanres.16048.
BACKGROUND/AIM: Vascularized (VFG) and non-vascularized fibula grafts (NVFG) are used in reconstruction of bone defects after tumour resection. This study compared both autografts and their results, risk factors, and complications.
Tumour resection and reconstruction by using VFG (n=17) and NVFG (n=36) were performed in 53 patients at our institute (range=3-65 years of age, mean: 21.2 ± 13.2 years) of which 24 were female. Malignant tumours were diagnosed in 26 patients (VFG=16 patients-94%). The mean follow-up was 14.9 years (range=1.5-43 years). Factors like consolidation, functional and oncologic outcomes, and complications were analysed.
In total, 75 struts of fibula were obtained. The mean length of the fibula was 16.3 cm (16 in NVFG and 16.5 in VFG). The mean union time was 13 months (6 to 25 months) overall. Hypertrophy was found in 65 of 75 grafts (86.7%) and consolidation was found in 69 (92%). Hypertrophy was similar in VFG (85.3%) and NVFG (87.1%). Complication rate in VFG was 41% and in NVFG 25%. Fractures were found in 7 (13%), infections in 4 (7.5%), and non-union in 5 (9.4%) patients. Chemotherapy was the only negative prognostic factor for union time (p=0.021).
Both VFG and NVFG are used with successful results in the reconstruction of segmental bone tumour defects. With lower complication rates, NVFG showed comparable results to VFG but is limited in indication by size for greater defects, and malignant tumours. Chemotherapy is an adverse factor leading to prolonged union time in both techniques.
背景/目的:带血管(VFG)和不带血管腓骨移植(NVFG)用于肿瘤切除后骨缺损的重建。本研究比较了两种自体移植物及其结果、风险因素和并发症。
在我们医院,对 53 名患者(年龄 3-65 岁,平均 21.2±13.2 岁,其中 24 名女性)进行了肿瘤切除和 VFG(n=17)和 NVFG(n=36)重建。26 例患者诊断为恶性肿瘤(VFG=16 例-94%)。平均随访时间为 14.9 年(范围 1.5-43 年)。分析了骨愈合、功能和肿瘤学结果以及并发症等因素。
共获得 75 根腓骨支柱。腓骨平均长度为 16.3cm(NVFG 为 16 英寸,VFG 为 16.5 英寸)。总体而言,平均愈合时间为 13 个月(6-25 个月)。75 个移植物中有 65 个(86.7%)出现肥大,69 个(92%)出现骨愈合。VFG(85.3%)和 NVFG(87.1%)的肥大程度相似。VFG 的并发症发生率为 41%,NVFG 为 25%。7 例(13%)发生骨折,4 例(7.5%)发生感染,5 例(9.4%)发生骨不连。化疗是影响愈合时间的唯一负预后因素(p=0.021)。
带血管和不带血管腓骨移植均可成功用于重建节段性骨肿瘤缺损。NVFG 的并发症发生率较低,与 VFG 结果相当,但由于尺寸限制,对较大的缺损和恶性肿瘤的适应证有限。化疗是两种技术中导致愈合时间延长的不利因素。